UK scientists developing Ebola vaccine that could be ready for trials in months

• UK researchers are developing a vaccine against Bundibugyo ebolavirus, a rare species with ~33% mortality and no currently approved vaccine
• The vaccine could enter clinical trials within months, offering potential protection against this understudied pathogen
• This addresses a significant gap in preparedness for a neglected but lethal viral threat with pandemic potential

The rare species of Ebola involved - known as Bundibugyo - kills around a third of those infected and has no proven vaccine yet.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.